Clinical Trial Update: Neuroimaging and CBD for Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neuroimaging biomarkers and cannabidiol for opioid use disorder (heroin use disorder) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Use Disorder
• Opioid Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Yasmin Hurd | Conditions: Heroin Abuse, Opioid Use Disorder | Phase 2 | Status: COMPLETED